Sathish, Jean G.
Pfizer (United States)
3 papers on CoChatORCID 0000-0002-5605-6957
Most cited papers
- Verified
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K. J., et al. (2021) · Science
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 2,033
- Verified
High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo
Antoine, D. J., Williams, D. P., Kipar, A., Jenkins, R. E., Regan, S. L., Sathish, J. G., Kitteringham, N. R., & Park, B. K. (2009) · Toxicological Sciences
Drug-Induced Hepatotoxicity and ProtectionCell death mechanisms and regulation
Cited by 223
- Verified
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Boras, B., Jones, R. M., Anson, B. J., Arenson, D., Aschenbrenner, L., Bakowski, M. A., Beutler, N., Binder, J., Chen, E., Eng, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory)
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 154
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free